Top Story

Minimally invasive surgical approaches inferior to open resection for rectal cancer

October 9, 2015

The use of minimally invasive laparoscopic resection did not improve outcomes compared with open resection for patients with rectal cancer, according to the results of two randomized trials.

Surgery remains the primary strategy to treat rectal cancer. Thus, researchers sought to determine whether laparoscopic procedures — generally believed to produce better outcomes than open resections — were noninferior to open procedures. Due to anatomical constraints that may lead to inadequate resection, laparoscopic rectal resection may not be preferable.

Jason Wright In the Journals

Risks, benefits of power morcellation differ based on patient age

October 8, 2015
Minimally invasive hysterectomies with electric power morcellation have varying risks and benefits depending on a woman’s age, according to results of a cohort…
Susan Vadaparampil In the Journals

Young black women have higher frequency of BRCA mutations than previously thought

October 8, 2015
The prevalence of BRCA mutations among young black women living in Florida appears greater than previously reported for non-Hispanic white women, according to findings…
In the JournalsPerspective

Genetic testing may improve myeloma risk stratification, treatment

October 8, 2015
Researchers have identified significantly mutated genes in patients with newly diagnosed myeloma that may be used to improve risk stratification and treatment at disease…
Frank A. Sinicrope, MD In the Journals

Tumor mutations, survival in stage 3 colon cancer differ by race

October 8, 2015
Genetic tumor mutations status in BRAF and KRAS genes and survival rates in stage 3 colon cancer patients differ based on race, according to an analysis of a phase 3…
More News Headlines »
Diabetic Eye Disease Consults: Volume 1, Number 1

Updates in Melanoma 2015: Entering a New Therapeutic Era

This activity is supported by an educational grant from Merck & Co., Inc.

The incidence of melanoma, an aggressive disease that accounts for approximately 75% of skin-cancer-related deaths, is…
More »
VIDEO: Targeted combination therapies become touchstone for care in advanced melanoma

VIDEO: Targeted combination therapies become touchstone for care in advanced melanoma

September 30, 2015
The development of new treatments for patients with advanced melanoma in the past decade has been…
More »
Hematology Oncology Case Consults

The Patient with Pancreatic Cancer

No commercial support for this activity.

Pancreatic cancer only accounts for 3% of cancer cases, but it is the fourth leading cause of cancer-related death…
More »